Auditory Interventions for Stuttering
Trial Summary
What is the purpose of this trial?
Stuttering negatively impacts communication and reduces the overall quality of life and well-being of individuals who stutter. This study will provide a strong foundation for developing neural and behavioral interventions for stuttering. Participants will be asked to name pictures, read words/sentences silently or aloud, and listen to speech and nonspeech sounds while their speech, muscle, and brain signals are collected. Some participants may also receive brain stimulation while reading and speaking.
Will I have to stop taking my current medications?
If you are taking any medications that affect the central nervous system, you will need to stop taking them to participate in this trial.
What data supports the effectiveness of the treatment Auditory Interventions for Stuttering?
Research shows that delayed auditory feedback (DAF) can help people who stutter by increasing their ability to modulate auditory processing before speaking, which is often limited in those who stutter. This treatment has been found to partially improve speech fluency in stutterers, even though it may disrupt speech in people who do not stutter.12345
Is delayed auditory feedback (DAF) safe for humans?
How does the auditory intervention treatment for stuttering differ from other treatments?
This treatment is unique because it uses delayed auditory feedback (DAF), where individuals hear their own voice with a slight delay, which can help normalize auditory processing in people who stutter. Unlike other treatments, DAF specifically targets the auditory feedback loop, which is often impaired in stuttering, to improve speech fluency.12345
Eligibility Criteria
This trial is for monolingual, native American English speakers who stutter but don't have other developmental, psychological, neurological disorders. They must have normal hearing and not be on central nervous system medications. Adults can't have conditions that make brain stimulation or MRI unsafe.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in tasks such as naming pictures, reading words/sentences, and listening to speech and nonspeech sounds while their speech, muscle, and brain signals are collected. Some participants may also receive brain stimulation.
Follow-up
Participants are monitored for changes in speech and brain activity in response to auditory errors and speech tasks.
Treatment Details
Interventions
- Auditory errors and pre-speech auditory modulation
- Contributions of the speech premotor cortex to pre-speech auditory modulation
- Delaying auditory feedback
- Delaying speech initiation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor
University of Washington
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator